By Wendy Sarubbi | February 21, 2017 4:56 pm

UCF College of Medicine Professor Dr. William DeCampli partnered with UCF Pegasus Professor Aristide Dogariu and doctoral student Jose Rafael Guzman-Sepulveda to develop a real-time blood monitor that has been successfully tested during open-heart surgery on infants.

The technology uses an optical fiber to beam light through a patient’s blood and interpret the signals that bounce back. Researchers believe that in some situations it could replace the need for doctors to wait while blood is drawn from a patient and tested.

“I absolutely see the technique having potential in the intensive care setting, where it can be part of saving the lives of critically ill patients with all kinds of other disorders,” said Dr. DeCampli.

Over the past year, Dr. DeCampli tested the technology during cardiac surgeries on 10 infants at Arnold Palmer Hospital for Children, where he is chief of pediatric cardiac surgery.

During surgery, physicians are wary of the patient’s blood coagulating, or clotting, too quickly. A clot can lead to life-threatening conditions such as stroke or pulmonary embolism. Coagulation is of particular concern during cardiovascular surgery, when a clot can shut down the heart-lung machine used to circulate the patient’s blood.

Doctors administer blood-thinning medication to prevent coagulation. But every 20-30 minutes, blood must be withdrawn and taken to a lab for a test that can take up to 10 minutes. That’s a slow process with gaps of time without up-to-date information, especially in operations that can last four hours or more.

Dr. Dogariu, a Pegasus Professor in UCF’s College of Optics & Photonics, developed a machine with an optical fiber that can tap directly into the tubes of the heart-lung machine. The optical fiber beams light at the blood passing through the tube and detects the light as it bounces back.

As reported in a paper published recently in the journal Nature Biomedical Engineering, the machine constantly interprets the light’s back-scatter to determine how rapidly red blood cells are vibrating. Slow vibration is a sign blood is coagulating and a blood-thinner may be needed.

The technology can alert doctors at the first sign of clotting, and provide nonstop information throughout a long procedure.

“It provides continuous feedback for the surgeon to make a decision on medication,” Dr. Dogariu said. “That is what’s new. Continuous, real-time monitoring is not available today. That is what our machine does, and in surgeries that can last for hours, this information can be critical.”

“The successful tests were the end result of a relationship facilitated by UCF,” Dr. DeCampli said, noting that the university encourages interdisciplinary collaboration among its faculty as a way to spark innovative breakthroughs. That’s how he came to work with Dr. Dogariu, who has spent years researching the application of light-detection technology in industrial uses like the manufacture of semiconductors and paints.

“These things come about because of collaboration between a top-ranked engineering university and a top-ranked children’s hospital all in one city,” Dr. DeCampli said. “I think it’s the perfect way to make advances in medicine that are at the engineering frontiers.”

Their recently published paper is based on a small, proof-of-concept study. The team plans to complete a larger study.

Post Tags

Related Stories